Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma
Stopped Experimental treatment not feasible due to high rate of drop out
Conditions
- Resectable Esophageal Cancer
Interventions
- DRUG: cetuximab
- RADIATION: radiotherapy to oesophageal tumour
Sponsor
P.O. Witteveen
Collaborators